Walleye Trading LLC Agenus Inc Transaction History

Walleye Trading LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$1.3 - $2.64 $29,308 - $59,518	-22,545 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $31,779 - $46,924	-13,523 Reduced 37.49%	22,545 $55,000
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $59,351 - $116,671	20,326 Added 129.12%	36,068 $116,000
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $78,395 - $104,369	15,742 New	15,742 $83,000
Q2 2021 Aug 16, 2021	SELL	$2.56 - $5.49 $60,300 - $129,316	-23,555 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.69 - $5.25 $63,362 - $123,663	23,555 New	23,555 $64,000
Q2 2018 Aug 14, 2018	SELL	$2.26 - $4.65 $63,338 - $130,320	-28,026 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.51 - $6.04 $98,371 - $169,277	28,026 New	28,026 $132,000
Q4 2017 Feb 14, 2018	SELL	$3.26 - $4.78 $104,320 - $152,960	-32,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.48 - $4.44 $90,480 - $115,440	26,000 Added 433.33%	32,000 $141,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,000	6,000 $23,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.